Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 86 results for "brian druker"

MOLECULARMD : Receives ISO Certification for Design, Developme...

- MolecularMD Corp., a molecular diagnostics company that develops custom companion diagnostics and provides clinical trial testing services for targeted cancer therapies, today announced the recent certification by BSI (British Standards ... 4 Traders, 4 days ago
[x]  

Aptose names Andreeff to scientific advisory board

Dr. William Rice reports APTOSE BIOSCIENCES ANNOUNCES APPOINTMENT OF DR. MICHAEL ANDREEFF TO SCIENTIFIC ADVISORY BOARD Aptose Biosciences Inc. has appointed Dr. Michael Andreeff, MD, PhD, professor of medicine, department of leukemia, division ...
 Stockwatch1 week ago Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory Board  Wall Street Select1 week ago
[x]  
Xconomy

Blueprint Cuts $265M Alexion Deal With IPO in Sight

3/3/15 Follow @benthefidler It's been a year of transition for Blueprint Medicines. Since early 2014, the Cambridge, MA-based company moved on from its founding CEO, named two lead programs, added a whole bunch of new investors, and raised a total ...
 Xconomy3 weeks ago
LifeHealthPro

Cancer Drug Once Bought for $7 Million May Now Fetch $18 Billion

(Bloomberg) -- An overlooked drug bought by a biotech company for a mere $6.6 million a decade ago could become one of the biggest selling cancer treatments ever. Those high expectations have its maker, Pharmacyclics Inc., considering selling ...
 Bloomberg1 month ago Cancer drug once bought for US$7m may now fetch US$18b  Today Online1 month ago
[x]  

Bay Area's Pharmacyclics Mulls Possible $18 Billion Sale; Johnson & Johnson,Novartis AG Interested

February 26, 2015 By Mark Terry , BioSpace.com Breaking News Staff Rumors are spreading that Sunnyvale, Calif.-based Pharmacyclics, Inc. ( PCYC ) may be looking for a buyer, woth unidentified sources telling Bloomberg Wednesday that Johnson & ...
 BioSpace1 month ago
Ecologist

Kindness that kills - Trans-Pacific Partnership's Big Pharma giveaway

18th February 2015 Out of all big industries making billions in profit, the pharmaceutical is probably the most ethically questionable. The Trans-Pacific Partnership (TPP) trade deal is causing quite a stir around the world, and for good reason.
 Ecologist1 month ago

OHSU Knight Cancer Institute awards more than $460,000 to community projects

AAAS Annual Meeting 12-16 February, 2015 San Jose, California EurekAlert! provides embargoed and breaking science news you can't afford to miss. EurekAlert! offers a one-stop science news distribution service you can trust. EurekAlert! is a ...
 EurekAlert!1 month ago

Earlier Detection Needed to Take Chance Out of Cancer Survival

Ed McLaughlin thought he was in the best shape of his life. The president of a Denver-based oil and gas energy company, McLaughlin had just completed a 100-mile bicycle ride and a half-marathon. But a routine blood test found otherwise. It revealed ...
 CancerConnect.com1 month ago

Paul Tang, M.D. at iHT2-San Diego: Patients 3.0: What's the Job of a Patient?

Moving towards the new person-centered healthcare is going to require a dual revolution in thinking, says Paul Tang, M.D. Renowned industry leader Paul Tang, M.D., vice president and chief innovation and technology officer at the Palo Alto ...
 Healthcare Informatics Online2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less